BeStock  
Stocks › Biotechnology › ALNY

Alnylam Pharmaceuticals ALNY

US equityMarket cap rank #931Biotechnology
$143.82 −$4.00 (-2.71%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $144.50 +0.47%
Open$148.35
Prev close$147.82
Day range$143.40 – $151.41
Volume2.33M
Market cap$19.26B
P/E (TTM)7.5
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership104.2%-0.09 pts vs. prior quarter
Institutions holding950-3 vs. prior quarter
Insider trades (recent)31 buys / 17 sellsNet buying
Short interest4.08% of floatDays to cover 1.9 · as of 30 Oct 2026
Short-sale volume share9.0%5-day average of daily volume

Short-sale volume as % of daily volume

3%7%11%14%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$187.22M (2 inflow days, 18 outflow days).

Net flow by order size, last 20 sessions

−$183.4MSuper−$3.8MBig−$7.5MMid+$130.4KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 49.0% of shares outstanding.

Largest holders

  • Capital Research18.57%
  • FMR9.00%
  • BlackRock8.23%
  • T. Rowe Price Group, Inc.8.03%
  • Vanguard Capital Management, LLC5.14%
  • Vanguard Portfolio Management, LLC5.00%
  • Baillie Gifford4.10%
  • State Street Global Advisors2.85%

By investor type

  • Mutual Fund91.35%
  • Hedge Fund4.50%
  • Public Company3.56%
  • Sovereign Wealth Fund1.77%
  • Government Pension Fund1.52%
  • Private Company0.84%
  • VC/PE Fund0.26%
  • Insurance Company0.20%

Reported short interest has risen from 3.57% to 4.08% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
T. Rowe Price Group, Inc. Mutual Fund 2026/Q4 +3,968,086 8.0%
Capital Research Mutual Fund 2026/Q4 +3,860,508 18.6%
Baillie Gifford Mutual Fund 2026/Q4 +3,052,580 4.1%
Wellington Management Group Mutual Fund 2026/Q4 +1,368,097 2.6%
AQR Capital Management Hedge Fund 2026/Q4 +952,922 1.2%
Bank of America Corporation Public Company 2026/Q4 +713,650 1.1%
Brown Advisory Incorporated Mutual Fund 2026/Q4 +697,360 0.6%
Orbis Investment Management Limited Mutual Fund 2026/Q4 +433,768 1.8%
Polar Capital Holdings Plc Mutual Fund 2026/Q4 +271,046 0.6%
State Street Global Advisors Mutual Fund 2026/Q4 +261,617 2.9%
Manulife Asset Management Mutual Fund 2026/Q4 +257,935 0.9%
Bellevue Asset Management AG Mutual Fund 2026/Q4 +239,230 0.2%
The Goldman Sachs Group, Inc. Public Company 2026/Q4 +236,438 0.3%
Holocene Advisors, LP Hedge Fund 2026/Q4 +217,000 0.2%
Pictet Asset Management Limited Mutual Fund 2026/Q4 +216,555 0.4%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
9 Nov 2026 David E. Pyott Independent Director Derivative Exercise and Retained +3,780 $71.99 32,591
9 Nov 2026 Charles Sigal Independent Director Open Market Acquisition +1,600 $152.25 4,375
8 Nov 2026 Amy W. Schulman Independent Chairperson Open Market Acquisition +1,910 $156.82 25,121
1 Oct 2026 Bryan Supran Chief Legal Officer Open Market Disposition -1,758 $226.88 2,584
1 Oct 2026 Bryan Supran Chief Legal Officer Intent to Sell (Form 144) -1,758 $226.88 –
18 Sep 2026 Yvonne Greenstreet Chief Executive Officer Other Acquisition +107 – 62,470
31 May 2026 David E. Pyott Independent Director Derivative Exercise and Sale -3,830 $302.65 28,811
31 May 2026 Benjamin Cravatt Director Other Derivative Acquisition +4,393 $295.63 4,393
19 May 2026 Peter Kellogg Independent Director Other Acquisition +671 – 671
19 May 2026 Peter Kellogg Independent Director Other Derivative Acquisition +1,441 $298.48 1,441
19 May 2026 David E. Pyott Independent Director Other Acquisition +671 – 671
19 May 2026 David E. Pyott Independent Director Other Derivative Acquisition +1,441 $298.48 1,441
19 May 2026 Charles Sigal Independent Director Other Acquisition +671 – 671
19 May 2026 Charles Sigal Independent Director Other Derivative Acquisition +1,441 $298.48 1,441
19 May 2026 Margaret Hamburg Independent Director Other Acquisition +671 – 671
19 May 2026 Margaret Hamburg Independent Director Other Derivative Acquisition +1,441 $298.48 1,441
19 May 2026 Amy W. Schulman Independent Chairperson Other Acquisition +838 – 838
19 May 2026 Amy W. Schulman Independent Chairperson Other Derivative Acquisition +1,802 $298.48 1,802
19 May 2026 Dennis Ausiello Member of the Scientific Advisory Board & Independent Director Other Acquisition +671 – 671
19 May 2026 Dennis Ausiello Member of the Scientific Advisory Board & Independent Director Other Derivative Acquisition +1,441 $298.48 1,441

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 5,465,979 4.1% 1.9
15 Oct 2026 6,568,786 4.9% 5.1
30 Sep 2026 7,711,495 5.8% 6.5
15 Sep 2026 7,194,097 5.4% 4.1
31 Aug 2026 6,340,087 4.7% 3.9
14 Aug 2026 4,770,978 3.6% 2.4

Discussion

No comments yet — be the first to weigh in on ALNY.

Sign in to join the discussion.

Scroll to Top